Introducing Sofosbuvir/Velpatasvir + Ribavirin as a Generic Retreatment Regimen for Hepatitis C: Evaluation of a

Janvier Serumondo1, Peter Barebwanuwe2, Ephrem Daniel Sheferaw2

  • 1Rwanda Ministry of Health, Rwanda Biomedical Center, Kigali, Rwanda.

Abstract